Bringing ingenuity to drug development
We are developing a unique immuno-modulatory antibody to treat COVID-19 patients.
We are passionate about finding clever ways to design new medicines with precise mechanisms of action to improve the lives of patients with the most difficult-to-treat cancers. We have a deep pipeline of investigational medicines that we are efficiently advancing in preclinical studies and in intelligently-designed, rigorously-conducted clinical trials.
